Stocks News

LAST PRICE
40.7450
TODAY'S CHANGE (%)
Trending Down-0.4950 (-1.2003%)

Bid / Lots
40.7400/ 5
Ask / Lots
40.7500/ 6
Open / Previous Close
41.2000 / 41.2400
Day Range
Low 40.6350
High 41.2400
52 Week Range
Low 33.3300
High 43.8400
Volume
693,752
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- CureVac Begins Early Stage Portion of Investigational Vaccine Trial, from 31 minutes ago by MT Newswires
  31 minutes ago by MT Newswires
  Companies Mentioned: GSK, CVAC
  12:27 PM EDT, 04/24/2024 (MT Newswires) -- CureVac (CVAC) said Wednesday it initiated the early stage portion of a broader study into an investigational flu vaccine developed with GSK (GSK). The phase 1 trial is part of a combined phase 1/2 study of...
- GSK's Application for Jemperli's Expanded Indication Accepted by FDA for Priority Review, from 2 hours ago by MT Newswires
  2 hours ago by MT Newswires
  Companies Mentioned: GSK
  10:38 AM EDT, 04/24/2024 (MT Newswires) -- GSK (GSK) said Wednesday that the US Food and Drug Administration granted priority review to its supplemental Biologics License Application for Jemperli in combination with chemotherapy to expand treatment ...
Apr 17, 2024
- GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix, from 9:18AM ET on Wednesday Apr 17, 2024 by MT Newswires
  9:18AM ET on Wednesday Apr 17, 2024 by MT Newswires
  Companies Mentioned: GSK
  09:18 AM EDT, 04/17/2024 (MT Newswires) -- GSK (GSK) on Wednesday reported positive results from phase 3 trials for gepotidacin, an oral antibiotic to treat urogenital gonorrhea, and Shingrix, its shingles vaccine. The drug maker said gepotidacin ac...
Apr 16, 2024
- GSK Says US FDA Accepts Meningococcal Vaccine Candidate for Regulatory Review, from 8:14AM ET on Tuesday Apr 16, 2024 by MT Newswires
  8:14AM ET on Tuesday Apr 16, 2024 by MT Newswires
  Companies Mentioned: GSK
  08:14 AM EDT, 04/16/2024 (MT Newswires) -- GSK (GSK) said in a regulatory filing Tuesday that the US Food and Drug Administration has accepted for review the company's biologics license application for its meningococcal ABCWY vaccine candidate. The ...
Apr 9, 2024
- DJ Pfizer to Ask FDA to Extend RSV Shot Approval to All Adults -- Barrons.com, from 6:45AM ET on Tuesday Apr 09, 2024 by Dow Jones
  6:45AM ET on Tuesday Apr 09, 2024 by Dow Jones
  Companies Mentioned: GSK, PFE, MRNA
  
  Josh Nathan-Kazis
  
  Pfizer said early Tuesday that it will ask the Food and Drug Administration to expand the approval of its respiratory syncytial virus vaccine to include all adults over the age of 18.

Today
- --BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: NVS
- Novartis Says New Malaria Drug Formulation Safe and Effective for Babies, from 2 hours ago by MT Newswires
  2 hours ago by MT Newswires
  Companies Mentioned: NVS
Yesterday
- US Equity Markets Close Higher Tuesday, from 20 hours ago by MT Newswires
  20 hours ago by MT Newswires
  Companies Mentioned: NVS, X, CLF
- Sector Update: Health Care Stocks Rise Late Afternoon, from 21 hours ago by MT Newswires
  21 hours ago by MT Newswires
  Companies Mentioned: SNY, UNH, ABEO, DHR
- Sector Update: Health Care, from 21 hours ago by MT Newswires
  21 hours ago by MT Newswires
  Companies Mentioned: SNY
- Novartis Wins FDA Approval of Pancreatic Tumor Therapy in Children, from 21 hours ago by MT Newswires
  21 hours ago by MT Newswires
  Companies Mentioned: NVS
- Market Chatter: Sanofi Asks Banks to Pitch for Roles on Separation of Consumer Health Care Business, from 22 hours ago by MT Newswires
  22 hours ago by MT Newswires
  Companies Mentioned: SNY
- Top Midday Stories: Shares of GE, Novartis, Danaher and Philip Morris Up Post-Earnings; Pepsi Stock Down Post-Earnings; Apple iPhone China Sales Drop 19%; Trump Poised for Windfall From Media Company Stock, from 12:24PM ET on Tuesday Apr 23, 2024 by MT Newswires
  12:24PM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: PM, NEE, GE, LMT, NVS, PEP, TTE, UNH, UPS, RTX, X, AAPL, BA, SPR, DJT, SHEL, CLF, DHR
- Sector Update: Health Care Stocks Steady Pre-Bell Tuesday, from 9:04AM ET on Tuesday Apr 23, 2024 by MT Newswires
  9:04AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: IBB, NVS, XLV, DGX, DHR
- Novartis Q1 Core Earnings, Net Sales Rise; 2024 Net Sales Outlook Updated, from 7:45AM ET on Tuesday Apr 23, 2024 by MT Newswires
  7:45AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: NVS

GSK plc
NYSE:GSKUnited States

Search Criteria

Today

CureVac Begins Early Stage Portion of Investigational Vaccine Trial, from 31 minutes ago by MT Newswires

GSK's Application for Jemperli's Expanded Indication Accepted by FDA for Priority Review, from 2 hours ago by MT Newswires

Apr 17, 2024

GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix, from 9:18AM ET on Wednesday Apr 17, 2024 by MT Newswires

Apr 16, 2024

GSK Says US FDA Accepts Meningococcal Vaccine Candidate for Regulatory Review, from 8:14AM ET on Tuesday Apr 16, 2024 by MT Newswires

Apr 9, 2024

DJ Pfizer to Ask FDA to Extend RSV Shot Approval to All Adults -- Barrons.com, from 6:45AM ET on Tuesday Apr 09, 2024 by Dow Jones

Peers Headlines

Today

--BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating, from 1 hour ago by MT Newswires

Novartis Says New Malaria Drug Formulation Safe and Effective for Babies, from 2 hours ago by MT Newswires

Yesterday

US Equity Markets Close Higher Tuesday, from 20 hours ago by MT Newswires

Sector Update: Health Care Stocks Rise Late Afternoon, from 21 hours ago by MT Newswires

Sector Update: Health Care, from 21 hours ago by MT Newswires

Novartis Wins FDA Approval of Pancreatic Tumor Therapy in Children, from 21 hours ago by MT Newswires

Market Chatter: Sanofi Asks Banks to Pitch for Roles on Separation of Consumer Health Care Business, from 22 hours ago by MT Newswires

Top Midday Stories: Shares of GE, Novartis, Danaher and Philip Morris Up Post-Earnings; Pepsi Stock Down Post-Earnings; Apple iPhone China Sales Drop 19%; Trump Poised for Windfall From Media Company Stock, from 12:24PM ET on Tuesday Apr 23, 2024 by MT Newswires

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday, from 9:04AM ET on Tuesday Apr 23, 2024 by MT Newswires

Novartis Q1 Core Earnings, Net Sales Rise; 2024 Net Sales Outlook Updated, from 7:45AM ET on Tuesday Apr 23, 2024 by MT Newswires